Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Delivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challenges
Eman A. Taha, Joseph Lee, Akitsu Hotta
Journal of Controlled Release (2022) Vol. 342, pp. 345-361
Open Access | Times Cited: 158

Showing 1-25 of 158 citing articles:

CRISPR technology: A decade of genome editing is only the beginning
Joy Y. Wang, Jennifer A. Doudna
Science (2023) Vol. 379, Iss. 6629
Closed Access | Times Cited: 608
Therapeutic in vivo delivery of gene editing agents
Aditya Raguram, Samagya Banskota, David R. Liu
Cell (2022) Vol. 185, Iss. 15, pp. 2806-2827
Open Access | Times Cited: 294
Off-target effects in CRISPR/Cas9 gene editing
Congting Guo, Xiaoteng Ma, Fei Gao, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 205
Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer Therapy
Yan Zong, Yi Lin, Tuo Wei, et al.
Advanced Materials (2023) Vol. 35, Iss. 51
Closed Access | Times Cited: 180
Extrahepatic targeting of lipid nanoparticles in vivo with intracellular targeting for future nanomedicines
Takashi Nakamura, Yusuke Sato, Yuma Yamada, et al.
Advanced Drug Delivery Reviews (2022) Vol. 188, pp. 114417-114417
Open Access | Times Cited: 90
Prime editing: advances and therapeutic applications
Zhihan Zhao, Peng Shang, Prarthana Mohanraju, et al.
Trends in biotechnology (2023) Vol. 41, Iss. 8, pp. 1000-1012
Open Access | Times Cited: 90
Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo
Meirui An, Aditya Raguram, Samuel W. Du, et al.
Nature Biotechnology (2024) Vol. 42, Iss. 10, pp. 1526-1537
Open Access | Times Cited: 89
Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
Mohammad Chehelgerdi, Matin Chehelgerdi, Milad Khorramian‐Ghahfarokhi, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 72
Principles of CRISPR-Cas9 technology: Advancements in genome editing and emerging trends in drug delivery
Alaa A. A. Aljabali, Mohamed El‐Tanani, Murtaza M. Tambuwala
Journal of Drug Delivery Science and Technology (2024) Vol. 92, pp. 105338-105338
Open Access | Times Cited: 45
Unintended CRISPR-Cas9 editing outcomes: a review of the detection and prevalence of structural variants generated by gene-editing in human cells
John Hunt, Christopher Samson, Alex du Rand, et al.
Human Genetics (2023) Vol. 142, Iss. 6, pp. 705-720
Open Access | Times Cited: 44
Regulatory insights into nanomedicine and gene vaccine innovation: Safety assessment, challenges, and regulatory perspectives
Eliana B. Souto, Cristina Blanco-Llamero, Karolline Krambeck, et al.
Acta Biomaterialia (2024) Vol. 180, pp. 1-17
Open Access | Times Cited: 38
Bacterial protoplast-derived nanovesicles carrying CRISPR-Cas9 tools re-educate tumor-associated macrophages for enhanced cancer immunotherapy
Mingming Zhao, Xiaohui Cheng, Pingwen Shao, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 25
Polymer-locking fusogenic liposomes for glioblastoma-targeted siRNA delivery and CRISPR–Cas gene editing
Yu Zhao, Jie Qin, Daohan Yu, et al.
Nature Nanotechnology (2024) Vol. 19, Iss. 12, pp. 1869-1879
Closed Access | Times Cited: 20
Advancing Therapeutic Strategies with Polymeric Drug Conjugates for Nucleic Acid Delivery and Treatment
Aftab Ullah, Marina Khan, Yibang Zhang, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 25-52
Open Access | Times Cited: 2
Current approaches in CRISPR-Cas9 mediated gene editing for biomedical and therapeutic applications
Gargi Bhattacharjee, Nisarg Gohil, Khushal Khambhati, et al.
Journal of Controlled Release (2022) Vol. 343, pp. 703-723
Closed Access | Times Cited: 53
Immunogenicity of CRISPR therapeutics—Critical considerations for clinical translation
Radwa Ewaisha, Karen S. Anderson
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 42
Advances in siRNA delivery approaches in cancer therapy: challenges and opportunities
Houman Isazadeh, Farshid Oruji, Shima Shabani, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 11, pp. 9529-9543
Closed Access | Times Cited: 33
The CRISPR/Cas9 System Delivered by Extracellular Vesicles
Xinglong Zhu, Mengyu Gao, Yongfeng Yang, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 984-984
Open Access | Times Cited: 29
Deciphering the recent trends in pesticide bioremediation using genome editing and multi-omics approaches: a review
Shahnawaz Hassan, Bashir Ahmad Ganai
World Journal of Microbiology and Biotechnology (2023) Vol. 39, Iss. 6
Closed Access | Times Cited: 23
Optimizing CRISPR/Cas9 precision: Mitigating off-target effects for safe integration with photodynamic and stem cell therapies in cancer treatment
J. P. Jose Merlin, Heidi Abrahamse
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117516-117516
Open Access | Times Cited: 13
Nucleic acid drugs: recent progress and future perspectives
Xiaoyi Sun, Sarra Setrerrahmane, Chencheng Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 13
Genetically engineered hypoimmunogenic cell therapy
Akitsu Hotta, Sonja Schrepfer, András Nagy
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 11, pp. 960-979
Closed Access | Times Cited: 10
Advances in liposome-based delivery of RNA therapeutics for cancer treatment
Mehdi Sanati, Amir R. Afshari, Seyed Sajad Ahmadi, et al.
Progress in molecular biology and translational science (2024), pp. 177-218
Closed Access | Times Cited: 9
Breaking genetic shackles: The advance of base editing in genetic disorder treatment
Fang Xu, Caiyan Zheng, Weihui Xu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 9
Vectors in CRISPR Gene Editing for Neurological Disorders: Challenges and Opportunities
Kexin Xiong, Xiaoxia Wang, C. Q. Feng, et al.
Advanced Biology (2025)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top